DISCLOSEDStale
Oaktree Capital Management
Halozyme Therapeutics Inc · NASDAQ
2,000,000 sh · $2.0M
Filed 30 Jun 2025SEC 13Fview source
Oaktree Capital Management
Halozyme Therapeutics Inc · NASDAQ
2,000,000 sh · $2.0M
BlackRock
Halozyme Therapeutics Inc · NASDAQ
30,880,000 sh · $29.4M